Biosynex (ALBIO) — Free Cash Flow Generation Index

Latest as of December 2024: -1.19x

Biosynex (ALBIO) has a Free Cash Flow Generation Index of -1.19x as of December 2024. Free cash flow of €-1.51 Million represents -1% of operating cash flow (€1.26 Million). Read Biosynex (ALBIO) total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

-1.19x
Free Cash Flow / Operating CF

Free Cash Flow

€-1.51 Million
EUR

Operating Cash Flow

€1.26 Million
EUR

Capital Expenditures

€2.77 Million
EUR

Biosynex Free Cash Flow Generation Index (2009–2022)

Historical FCF Generation Index trend for Biosynex across 9 annual periods. Explore reinvestment intensity of Biosynex to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Biosynex (2009–2022)

Year-by-year Free Cash Flow Generation Index for Biosynex. For the full company profile including market capitalisation, see Biosynex market cap and net worth.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2022 -5.08x €-25.13 Million €4.95 Million €30.08 Million ▼ -714.6%
2021 0.83x €90.82 Million €109.83 Million €19.02 Million ▲ +16.2%
2020 0.71x €22.52 Million €31.64 Million €9.12 Million ▼ -28.8%
2019 1.00x €1.10 Million €1.10 Million €9.12 Million ▲ +0.0%
2018 1.00x €467.12K €467.12K €9.12 Million ▲ +0.0%
2017 1.00x €484.82K €484.82K €9.12 Million ▲ +0.0%
2016 1.00x €489.91K €489.91K €0.00 ▲ +0.0%
2015 1.00x €461.66K €461.66K €0.00 ▲ +184.2%
2009 0.35x €25.48K €72.40K €46.92K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).